ABSTRACT Prostaglandins (PGs) have modulatory effects on spontaneous and nicotine-induced release of acetylcholine (ACh) from the myenteric plexus of guinea pig ileum. To determine whether cyclic AMP is involved in the mechanisms of these effects, we studied ACh release under conditions that inhibit PG synthesis. Indomethacin (IND), a cyclooxygenase inhibitor, inhibited ACh release concentration-dependently. The effect of the maximally inhibitory concentration of IND (2.8 ,u M) on nicotine-induced ACh release were reversed concentration-dependently by PGE2, forskolin, 3-isobutyl 1-methylxanthine (IBMX) and 8-bromo cyclic AMP. These compounds caused concentration-dependent reversal of the inhibition of spontaneous ACh release by IND, but their concentrations for restoration of spontaneous release were higher than those for restoration of nicotine-induced release. The effects of PGE2 and forskolin or IBMX were not additive in reversing the inhibition of nicotine-induced ACh release by IND. Neither forskolin nor 8-bromo cyclic AMP alone had any significant effect on either release. These results showed that increase in the level of cyclic AMP in myenteric cholinergic neurons restored ACh release from the tissue whose PG level had been lowered by IND and indicated that endogenous PGs may modulate the level of intraneuronal cyclic AMP.
Inhibition of prostaglandin (PG) synthesis by in domethacin (IND), an inhibitor of cyclooxygenase (1) , enhances noradrenaline release from adrenergic nerves in various tissues (2) . On the contrary, IND inhibits nicotine-induced release of acetylcholine (ACh) from cholinergic nerves within the myenteric plexus of guinea pig ileum, and PGE2 significantly reverses this inhibi tion (3) . Excitation of adrenergic nerves results in a de crease of ACh release from the myenteric plexus in guinea pig ileum (4) , but studies on ACh release in the presence of antiadrenergic agents showed that the in hibitory effect of IND on ACh release was independent of the activities of adrenergic neurons (3) . We recently demonstrated that IND also inhibits substance P-in duced release of ACh from guinea pig ileum, but not that induced by electrical field stimulation or a high K+ concentration (5) . These results suggested that the modulatory effects of PGs are important for ACh re lease induced by activation of nicotinic ACh or tachy kinin receptors.
PGs are reported to act as endogenous Ca iono phores (6) and to enhance the influx of Ca 2+ from the external medium (7) . We found, however, that a change in the external Ca2+ concentration had only a slight influence on the modulatory effect of PGE2 on ACh release (8) , indicating that this effect of PGs can not be fully explained by their effects on Ca 2+ influx.
PGs are also reported to raise the intracellular level of cyclic adenosine 3',5'-monophosphate (cyclic AMP) in many tissues including peripheral neurons (9, 10) . Cyclic AMP has been suggested to be involved in the mechanisms regulating the release of neurotransmitters (for reviews, see 11, 12) . In the myenteric plexus of guinea pig ileum, forskolin, an adenylate cyclase activa tor (13, 14) , and dibutyryl or 8-bromo cyclic AMP, membrane-permeable cyclic AMP analogs (15) , induce the release of ACh (16, 17) , and drugs that increase the intracellular level of cyclic AMP enhance the electrically-evoked release of ACh (18, 19) . In the pres ent study, we examined whether cyclic AMP was in volved in the modulation by PGs of nicotine-induced ACh release from a longitudinal muscle preparation of the guinea pig ileum.
MATERIALS AND METHODS
Male guinea pigs, weighing 300 to 700g, were stunned and bled. The longitudinal muscle of the ileum with the myenteric plexus attached was removed as pre viously described (20) . The preparation was mounted in an organ bath containing 3 ml of Tyrode's solution of the following composition: 136.9 mM NaCl, 2.7 mM KC1, 1.8 mM CaC12, 1.05 mM MgC12, 11.9 MM NaHCO3, 0.4 mM NaH2PO4 and 5.6 mM glucose.
Release of ACh induced by various stimuli
The strips were first equilibrated for 15 min by super fusion with Tyrode's solution, kept at 37°C and bubbled with 95%02 and 5% CO2 at a rate of 1-2 ml min-i. The Tyrode's solution was supplemented with physo stigmine salicylate (5 ,uM) to prevent enzymatic hydroly sis of ACh and with choline chloride (1 u M) to supply a substrate for ACh synthesis (20) . Then, the perfusion was stopped and the bathing medium was replaced by 3 ml of fresh Tyrode's solution containing physostigmine and choline at intervals of 1 min. Two consecutive sam ples were collected for measurement of spontaneous ACh release, and then the strips were stimulated for 1 min by addition of nicotine (6.16,uM) . The stimulus was applied twice with an interval of 19 min between stimuli. The first stimulation (S1) was carried out in the absence of the appropriate modifying drugs, and the second (S2) in their presence. The drugs were admin istered 17 min before S2, except for PGE2 and 8-bromo cyclic AMP (1 mM). According to previous reports (5, 21) , PGE2 and 8-bromo cyclic AMP (1 mM) were added 2 min before S2. All samples collected were kept on ice until assayed (within 3 hr). At the end of the ex periment, the strips were blotted and weighed. The amount of ACh released per g tissue in response to each stimulation was calculated by subtracting the re lease in the preceding resting period of 1 min from the total output during the period of stimulation. The re lease of ACh during S2 was expressed as a percentage of that during S1.
Assay of released ACh
The samples collected were assayed for ACh using isolated strips of longitudinal muscle obtained as de scribed elsewhere (22) . For removal of the added nico tine and endogenous PGs, the samples were gently shaken with one-tenth volume of Amberlite XAD-2 for 15 min and filtered (3) . To eliminate the possibility of interference by other drugs present in the samples, we compared the responses to the bathing fluids with those of a standard solution of ACh supplemented with the tested drugs at the appropriate final concentration.
The active substance in the samples was identified as ACh by demonstrating that it was destroyed by boiling in alkali and that its action was antagonized by atropine and potentiated by physostigmine. In some experi ments, we confirmed that the release of ACh measured by bioassay was similar to that determined by high-per formance liquid chromatography (data not shown).
Statistical analyses were performed by Student's t-test.
Drugs
The following drugs were used: acetylcholine chloride (ACh), indomethacin (IND), physostigmine salicylate, forskolin and 8-bromo cyclic adenosine monophosphate (8-bromo cyclic AMP) (Sigma, U.S.A.); choline chlor ide and 3-isobutyl-l-methylxanthine (IBMX) (Aldrich, U.S.A.); and prostaglandin E2, a gift from Ono Phar maceutical Co. (Japan).
All other chemicals were of analytical grade. Stock solutions of IND, PGE2 and forskolin were prepared in ethanol, and those of other drugs in distilled water. Before use, these solutions were diluted appropriately with Tyrode's solution. Ethanol at the concentration used did not affect the release of ACh.
RESULTS
The amount of ACh released spontaneously im mediately before the first stimulation (R1, see the Methods) was 760.4 ± 100.6 pmol/g wet tissue/min (n = 8) and that immediately before the second stimula tion (R2) was not significantly different (R2/R1 = 119.5 ± 11.3%, n = 8). Addition of nicotine to the bathing fluid increased the ACh release concentration-depend ently (Fig. 1) . The maximum effect was obtained at 10 ,ug/ml (61.6 MM). Increasing the concentration to 100 u g/ml (616 p M) did not produce any further increase in the ACh release but somewhat decreased it, suggest ing the desensitization of the nicotinic receptor. There fore, we used a submaximal concentration, 1 ,ug/ml (6.16,uM) , to evaluate the effects of various drugs on the nicotine-induced release of ACh. The amount of ACh released by nicotine at 6.16 ,uM was 1495.3 ± 109.9 pmol/g wet tissue/min (n = 8). There was no sig nificant difference between the values for nicotine-in duced ACh release on the first (S1) and second (S2) sti mulations (S2/S1 = 98.2 ± 6.8%, n = 8). IND inhi bited both the spontaneous release and the nicotine-in duced release of ACh concentration-dependently, with IC50 values of 0.13 and 0.46 ,u M, respectively (Fig. 2) . It caused maximum inhibitions of both spontaneous and nicotine-induced release at 2.8,uM. Based on these re sults, IND was used at a concentration of 2.8 ,u M in the following experiments. Effects of PGE2 on IND-induced inhibitions of ACh release PGE2 alone at concentrations of 1-100 nM did not affect either the spontaneous release or the nicotine-in duced release of ACh (data not shown), but it reversed the inhibitory effect of IND on nicotine-induced ACh release significantly at concentrations of more than 2.8 nM, and maximally at 5.7 nM (Fig. 3) . It also reversed the inhibitory effect of IND on the spontaneous release of ACh significantly, although at a higher concentra tion. However, even at its maximally effective concen tration, the reversal by PGE2 of either release was in complete (Fig. 3) .
Effects of forskolin on IND-induced inhibitions of ACh release Forskolin (0.01 3 p M) also reversed the inhibitory effects of IND on the spontaneous release and the nicotine-induced ACh release concentration-dependent ly (Fig. 4A) . Its effect in restoration of the nicotine-in duced ACh release was detectable at 0.03 u M and com plete at 1 uM (Fig. 4A ), but its effect in restoration of spontaneous ACh release was still incomplete at 3 ,uM (Fig. 4A) .
Forskolin alone at 3 and 10,uM had no significant effect on either spontaneous or nicotine-induced release of ACh (data not shown).
Effects of 8-bromo cyclic AMP and IBMX on IND induced inhibitions of ACh release
8-Bromo cyclic AMP alone had no effect on either spontaneous or nicotine-induced release of ACh (data not shown), but it reversed the inhibitory effect of IND on these releases of ACh concentration-dependently (Fig. 4B) .
IBMX also reversed the inhibitory effect of IND on the nicotine-induced release of ACh completely at 50 ,uM, but had less effect in reversing the effect of IND on the spontaneous release (Fig. 4C) .
Effects of PGE2 in combination with forskolin or IBMX on IND-induced inhibitions of ACh release
Next, we examined whether the mechanisms of res toration of ACh release by PGE2, forskolin and IBMX were the same. Treatment with PGE2 in combination with forskolin or IBMX resulted in similar restoration of nicotine-induced release of ACh as the treatment with forskolin or IBMX alone (Table 1) . On the other hand, PGE2 reversed the inhibitory effect of IND on the spontaneous release of ACh in the presence of fors kolin or IBMX, although forskolin and IBMX alone had no effect and only a slight effect, respectively (Table 1) . (23) . Thus, the finding that PGE2 reversed the inhibitory effect of IND on nicotine-induced release of ACh concentration-de pendently, suggested that the inhibitory effect of IND on ACh release was due to a decrease in the level of endogenous PGs. PGs, including PGE, raise the level of cyclic AMP in peripheral nerves (9, 10) . We found that the inhibitory effect of IND on nicotine-induced release of ACh was also reversed concentration-depend ently by forskolin, IBMX and 8-bromo cyclic AMP. These three agents are known to induce cyclic AMP mediated responses by different mechanisms; forskolin directly stimulates adenylate cyclase (13) , IBMX in hibits phosphodiesterase (24) and 8-bromo cyclic AMP passes through the plasma membrane to act as cyclic AMP (15) . The finding that the effects of PGE2 and forskolin or IBMX were not additive suggests that PGE2 acted by raising the cyclic AMP level. Thus, the finding of reversion of IND-induced inhibition by these agents strongly suggested that increase of the cyclic AMP level induced by PGs is important for ACh re lease from the myenteric plexus.
Cyclic AMP is known to have physiological roles in the myenteric plexus of guinea pig ileum in regulating the neuronal function at two distinct sites. One site is the cell body of the neuron, as indicated by the electro physiological studies of Zafirov, Palmer and coworkers (25, 26) . The other site is nerve terminals: Reese and Cooper (17) showed that the increase of cyclic AMP induced by forskolin, IBMX or 8-bromo cyclic AMP re sulted in an increase in ACh release from synap tosomes. On the other hand, PGs have been suggested to modulate only excitation of the membrane of the cell body of the myenteric neurons, because IND did not affect ACh release induced by a high K+ concentra tion, which directly depolarizes the nerve terminals, or that induced by electrical field stimulation, which main ly excites the nerve axons (3, 27) . It seems likely, therefore, that an increase of cyclic AMP induced by PGE2 modulates the excitability of myenteric neurons in response to activation of nicotinic cholinergic recep tors on the cell body. Cheng and Shinozuka (28) also reported an important role of cyclic AMP in PGE2-in duced ACh release from the circular muscle of guinea pig ileum. However, their results cannot be discussed in relation with ours, because they examined ACh release induced by a high concentration of exogenous PGE2 (5 ,uM), whereas we examined that induced by activation of nicotinic cholinergic receptors.
The inhibitory effect of IND on the spontaneous release of ACh was significantly restored by agents that raise the intracellular level of cyclic AMP. However, higher concentrations of these agents were needed to restore the spontaneous release of ACh than to restore the nicotine-induced one. This finding suggested that the level of intracellular cyclic AMP required to main tain the spontaneous release of ACh is higher than that to maintain the nicotine-induced release. The reason for this difference in the cyclic AMP-dependencies of the two types of release cannot be explained at present. However, in this connection, it is interesting that the storage sites of ACh for spontaneous release and stimulus-induced release are suggested to be different in mouse brain (29) , and that galanin was shown to have different effects on spontaneous release and stimuli induced release of ACh from the myenteric plexus of guinea pig ileum (30) .
In the absence of IND, PGE2, forskolin and 8-bromo cyclic AMP alone at the concentrations used in the present study did not enhance spontaneous or nicotine induced release of ACh. These findings are compatible with a report that IBMX alone at concentrations of up to 1 mM did not affect either type of ACh release (21) . It seems likely that sufficient cyclic AMP for the modu lation of ACh release was present in the myenteric tissues under the present experimental conditions, and that the cyclic AMP level was maintained by arachido nate metabolites which were synthesized by spontaneous myenteric nerve activity. Inhibitions of the spontaneous releases of arachidonate metabolites and ACh from the preparation by hexamethonium supported the possibil ity (T. Takeuchi et al., unpublished data). On the other hand, Alberts and Ogren (18) reported that forskolin enhanced electrically-stimulated release of [3H]ACh in a concentration-dependent manner with a maximal effect of 50 ,uM, and Alberts and Stjarne (15) and Yau et al. (16) showed that forskolin and 8-bromo cyclic AMP increased the spontaneous [3H]ACh release from the myenteric plexus of guinea pig ileum. The discre pancy between these reports and the present results may be due to the difference in the stimuli used. McHugh and McGee (31) and Akagi and Kudo (32) suggested that forskolin at concentrations of more than 10 ,u M depressed the function of the neuronal nicotinic ACh receptors in PC 12 cells and rat sympathetic gang lia, respectively, by altering the lipid structure. Another possibility is a difference in methods. These workers studied release of [3H]ACh which had been synthesized from [3H]choline in the absence of physostigmine. Cheng and Shinozuka (33) and Alberts and Ogren (18) did not find any significant effects of forskolin on the spontaneous release of ACh in the presence of physo stigmine, in accordance with our results. Furthermore, we collected test specimens within 1-2 min after 8-bromo cyclic AMP treatment, but Yau et al. (16) noted that 8 bromo cyclic AMP significantly increased spontaneous re lease of ACh 5 to 10 min after its addition, but not within the first 5 min.
In the present study, even at high concentration, PGE2 did not completely restore either type of ACh release in the presence of IND. Treatment with IND de creased the levels of all metabolites whose formations were catalyzed by cyclooxygenase (1) . PGI2 stimulates the release of ACh from the myenteric plexus (34) , and PGD2 stimulates the activity of cholinergic neurons in guinea pig and canine trachea (35, 36) . Therefore, it seems likely that some other cyclooxygenase metabolite(s) besides PGE2 may contribute to the modulation of ACh release from myenteric cholinergic neurons.
In summary, we found that the inhibitory effects of IND on the release of ACh from the myenteric plexus of guinea pig ileum were reversed by agents that raise the intracellular level of cyclic AMP. These findings sug gested that the lowered level of PGs induced by IND treatment resulted in a decrease in the cyclic AMP level, which in turn decreased ACh release. Thus, endogenous PGs may modulate nicotine-induced release of ACh by regulating the cyclic AMP level in the cell body of the neurons.
